NYSE$ZEPP
ZEPP Health Corp.-ADR · Q4 2026 earnings
Q4 2026 earnings · · After market close · Investor relations
Briefing
Record gross margin and 43% revenue growth as Amazfit premium shift accelerates
Zepp Health reported Q4 2025 revenue of $85.2 million, up 43.0% year over year and at the top of guidance, driven by strong Amazfit-branded sales through Black Friday and holiday seasons. Gross margin hit a company-record 40.4%, up 360 bps YoY, reflecting a favorable premium product mix that offset memory-chip costs, tariffs, and FX headwinds. GAAP net loss narrowed to $11.0 million from $36.9 million; adjusted net loss was $6.4 million versus $22.5 million a year ago. Cash and restricted cash rose to $112.9 million while inventory fell to $72.8 million. Management guided Q1 2026 revenue of $50.0–$55.0 million (30%–43% YoY growth). Full-year 2025 revenue reached $258.9 million (+41.8%) with adjusted net loss of $31.5 million, down from $56.7 million in 2024.
- Q4 revenue of $85.2M (+43% YoY) beat guidance; FY2025 revenue $258.9M (+41.8%)
- Record Q4 gross margin of 40.4%, up 360 bps YoY on premium Amazfit mix
- GAAP net loss narrowed to $11.0M; adjusted net loss $6.4M vs $22.5M prior year
- Cash balance $112.9M; inventory reduced to $72.8M from $87.7M at Sep 30
- Q1 2026 revenue guidance $50.0M–$55.0M (+30% to +43% YoY)
Headline financials
Revenue & EPS history
ZEPP Health · Revenue · Quarterly
$85.2M
Forward guidance
Q1 2026 net revenue expected between $50.0 million and $55.0 million, representing approximately 30% to 43% year-over-year growth.
Tailwinds
- Continued premium product mix and margin expansion trajectory
- Strong Amazfit brand momentum into 2026
Headwinds
- Memory chip cost increases and tariff uncertainty remain headwinds
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q4 2026
-2.3%
Avg return
Earnings day
-3.4%
Avg return
5 days after
+1.6%
Avg return
30 days after
24%
9 / 37 earnings
Positive
+32.6%
Q2 2025
Best reaction
-29.3%
Q1 2027
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2027 | -29.3% | -24.1% | — | |
| Q1 2026 | +0.0% | -1.4% | -44.9% | |
| Q4 2026 | -12.1% | -17.3% | -13.5% | |
| Q3 2025 | -6.1% | -39.6% | -22.9% | |
| Q2 2025 | +32.6% | +91.2% | +312.8% | |
| Q1 2025 | -5.1% | -10.2% | -15.8% | |
| Q4 2024 | +15.3% | +2.7% | -9.7% | |
| Q3 2024 | -14.9% | -19.7% | -8.7% | |
| Q2 2024 | +19.7% | -3.3% | +10.0% | |
| Q1 2024 | -6.2% | -13.5% | -22.5% | |
| Q4 2023 | -8.5% | -17.0% | -29.4% | |
| Q3 2023 | +9.8% | -5.7% | +12.2% | |
| Q2 2023 | -4.2% | -5.8% | -6.7% | |
| Q1 2023 | -11.2% | -14.9% | -16.4% | |
| Q4 2022 | -6.9% | -11.5% | -11.5% | |
| Q3 2022 | -4.5% | -7.0% | +21.0% | |
| Q2 2022 | -9.1% | -7.2% | -28.8% | |
| Q1 2022 | -8.2% | -6.8% | -9.5% | |
| Q4 2021 | -0.6% | -1.3% | -15.1% | |
| Q3 2021 | -5.8% | -9.3% | -46.4% | |
| Q2 2021 | -1.0% | +10.7% | -5.6% | |
| Q1 2021 | -3.4% | +3.9% | +13.8% | |
| Q4 2020 | -2.1% | -10.2% | -28.6% | |
| Q3 2020 | -11.3% | -16.4% | -18.4% | |
| Q2 2020 | -11.1% | -8.8% | -4.2% | |
| Q1 2020 | -16.7% | -19.9% | -19.7% | |
| Q4 2019 | -5.2% | +1.7% | -2.8% | |
| Q3 2019 | +5.0% | +13.9% | +10.1% | |
| Q2 2019 | -1.5% | -14.0% | -5.7% | |
| Q1 2019 | +8.7% | +18.3% | +35.3% | |
| Q4 2018 | -7.9% | -13.9% | -18.1% | |
| Q3 2018 | -6.8% | +7.6% | -1.8% | |
| Q2 2018 | +9.1% | +4.7% | +0.4% | |
| Q1 2018 | +18.8% | +21.8% | +20.5% | |
| Q4 2015 | -1.5% | -0.9% | +21.6% | |
| Q4 2016 | -1.5% | -0.9% | +21.6% | |
| Q4 2017 | +0.1% | -0.5% | -15.3% | |
| Q3 2017 | — | — | — | |
| Q2 2017 | — | — | — | |
| Q1 2017 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro